Abstract
We sequentially assessed the presence of SARS-CoV-2 IgG antibodies in 1253 hospital workers including 1026 HCWs at the University Medical Center Hamburg-Eppendorf at three time points during the early phase of the epidemic. By the end of the study in July 2020, the overall seroprevalence was 1.8% (n = 22), indicating the overall effectiveness of infection control interventions in mitigating coronavirus disease 2019 (COVID-19) in hospital workers.
Keywords: COVID-19; Germany; Healthcare workers; Hospital workers; SARS-CoV-2; Seroprevalence.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Healthcare workers, Seroprevalence, Germany, Hospital workers, 【초록키워드】 coronavirus disease, infection control, hospital, Seroprevalence, Intervention, SARS-CoV-2 IgG antibody, Effectiveness, university, HCW, early phase, center, the epidemic, 【제목키워드】 hospital, Seroprevalence, SARS-CoV-2 antibody, Care, follow-up study,
【저자키워드】 COVID-19, SARS-CoV-2, Healthcare workers, Seroprevalence, Germany, Hospital workers, 【초록키워드】 coronavirus disease, infection control, hospital, Seroprevalence, Intervention, SARS-CoV-2 IgG antibody, Effectiveness, university, HCW, early phase, center, the epidemic, 【제목키워드】 hospital, Seroprevalence, SARS-CoV-2 antibody, Care, follow-up study,
{{{ 추상적인 }}}
우리는 전염병 초기 단계의 3개 시점에서 함부르크-에펜도르프 대학 의료 센터의 HCW 1026명을 포함하여 병원 직원 1253명의 SARS-CoV-2 IgG 항체 존재를 순차적으로 평가했습니다. 2020년 7월 연구가 끝날 때까지 전체 혈청 유병률은 1.8%(n = 22)였으며, 이는 병원 근로자의 코로나바이러스 질병 2019(COVID-19) 완화에 대한 감염 통제 중재의 전반적인 효과를 나타냅니다.
{{ 키워드: }} 코로나19; 독일; 의료 종사자; 병원 근로자; 사스 코로나바이러스 2; 혈청 유병률.